
DBV Technologies S.A. DBVT
€ 18.21
0.46%
Quartalsbericht 2025-Q2
hinzugefügt 29.07.2025
DBV Technologies S.A. P/S 2011-2026 | DBVT
P/S Jährlich DBV Technologies S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152 | 5.2 | 22.2 | 15.4 | - | - | - | - | - | 5.54 K | 3.71 K | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.54 K | 5.2 | 1.57 K |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
6.58 | $ 18.24 | -1.41 % | $ 2.68 B | ||
|
Amgen
AMGN
|
4.68 | $ 344.45 | 0.75 % | $ 185 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
7.54 | $ 73.14 | 5.5 % | $ 9.78 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Biogen
BIIB
|
2 | $ 178.43 | -0.81 % | $ 26 B | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.7 | 3.85 % | $ 17 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
35.6 | $ 2.87 | 4.36 % | $ 162 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.11 | -2.05 % | $ 7.48 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 9.77 | 0.83 % | $ 1.59 B | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.32 | $ 1.39 | -1.42 % | $ 261 M | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 222.86 | -1.43 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 4.12 | 2.74 % | $ 8.96 B | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 109.1 | -4.09 % | $ 27.2 B | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.39 | 1.09 % | $ 355 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Cardiff Oncology
CRDF
|
285 | $ 1.75 | -0.29 % | $ 83.4 M | ||
|
Compugen Ltd.
CGEN
|
49.8 | $ 1.85 | 0.54 % | $ 166 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 14.11 | 3.14 % | $ 4.36 B | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
3.81 | $ 6.64 | 0.91 % | $ 1.37 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Beam Therapeutics
BEAM
|
39.4 | $ 27.95 | 1.19 % | $ 2.3 B | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B |